These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25668819)

  • 21. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
    Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
    Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
    Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW
    Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling.
    Fan Z; Duan J; Wang L; Xiao S; Li L; Yan X; Yao W; Wu L; Zhang S; Zhang Y; Li Y; Zhu X; Hu Y; Zhang D; Jiao S; Xu X
    Cancer Lett; 2019 May; 450():132-143. PubMed ID: 30849480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway.
    Liu Y; Zhuang H; Cao F; Li J; Guo Y; Zhang J; Zhao Q; Liu Y
    Cell Death Dis; 2021 Mar; 12(3):278. PubMed ID: 33723262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.
    Chao HM; Huang HX; Chang PH; Tseng KC; Miyajima A; Chern E
    Oncotarget; 2017 Jan; 8(2):2604-2616. PubMed ID: 27911878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.
    Lei ZJ; Wang J; Xiao HL; Guo Y; Wang T; Li Q; Liu L; Luo X; Fan LL; Lin L; Mao CY; Wang SN; Wei YL; Lan CH; Jiang J; Yang XJ; Liu PD; Chen DF; Wang B
    Oncogene; 2015 Jun; 34(24):3188-98. PubMed ID: 25893304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
    Giovannini C; Gramantieri L; Chieco P; Minguzzi M; Lago F; Pianetti S; Ramazzotti E; Marcu KB; Bolondi L
    J Hepatol; 2009 May; 50(5):969-79. PubMed ID: 19304334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Ye YC; Zhao JL; Lu YT; Gao CC; Yang Y; Liang SQ; Lu YY; Wang L; Yue SQ; Dou KF; Qin HY; Han H
    Cancer Res; 2019 Aug; 79(16):4160-4172. PubMed ID: 31266773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
    World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
    Vilchez V; Turcios L; Marti F; Gedaly R
    World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dichlorodiphenyltrichloroethane exposure induces the growth of hepatocellular carcinoma via Wnt/β-catenin pathway.
    Jin XT; Song L; Zhao JY; Li ZY; Zhao MR; Liu WP
    Toxicol Lett; 2014 Feb; 225(1):158-66. PubMed ID: 24355586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis on the expression of the stem cells related genes in hepatocellular carcinoma cell lines].
    Zou C; Yuan FJ; Zhou WB; Huang L; Wang J; Zhang YS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):599-602. PubMed ID: 19719918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma.
    Gabata R; Harada K; Mizutani Y; Ouchi H; Yoshimura K; Sato Y; Kitao A; Kimura K; Kouji H; Miyashita T; Tajima H; Ohta T
    Anticancer Res; 2020 Sep; 40(9):5211-5219. PubMed ID: 32878809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.
    Lin YT; Chao CC
    Oncotarget; 2015 Nov; 6(36):38999-9017. PubMed ID: 26517516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Let7b modulates the Wnt/β-catenin pathway in liver cancer cells via downregulated Frizzled4.
    Cai H; Chen Y; Yang X; Ma S; Wang Q; Zhang Y; Niu X; Ding G; Yuan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716076. PubMed ID: 28671046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
    J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.